Alcohol treatment enhances Staphylococcus aureus biofilm development

FEMS Immunology and Medical Microbiology

Volumn 66, Issue 3, 2012, Pages 411-418

  Redelman, Carly V ^a,b   Maduakolam, Chike ^a   Anderson, Gregory G ^a  

^a INDIANA UNIVERSITY   (United States)

^b BUTLER UNIVERSITY   (United States)

Author keywords

Alcohol; Biofilm; Staphylococcus aureus

Indexed keywords

ALCOHOL;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL METABOLISM; BACTERIAL VIABILITY; BIOFILM; CONTROLLED STUDY; GENETIC TRANSCRIPTION; ICAA GENE; ICAD GENE; MEPA GENE; MMPL GENE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; VRAS GENE;

EID: 85027937406     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/1574-695X.12005     Document Type: Article

References (35)

1. Anderson GG, Moreau-Marquis S, Stanton BA & O'Toole GA (2008) In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect Immun 76: 1423-1433.
2. Anderson GG, Yahr TL, Lovewell RR & O'Toole GA (2010) The Pseudomonas aeruginosa magnesium transporter MgtE inhibits transcription of the type III secretion system. Infect Immun 78: 1239-1249.
3. Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME & Shirtliff ME (2011) Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2: 445-459.
4. Baba T, Bae T, Schneewind O, Takeuchi F & Hiramatsu K (2008) Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol 190: 300-310.
5. Boyle-Vavra S, Yin S & Daum RS (2006) The VraS/VraR two-component regulatory system required for oxacillin resistance in community-acquired methicillin-resistant Staphylococcus aureus. FEMS Microbiol Lett 262: 163-171.
6. Cassat J, Dunman PM, Murphy E, Projan SJ, Beenken KE, Palm KJ, Yang SJ, Rice KC, Bayles KW & Smeltzer MS (2006) Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology 152: 3075-3090.
7. Chiller K, Selkin BA & Murakawa GJ (2001) Skin microflora and bacterial infections of the skin. J Investig Dermatol Symp Proc 6: 170-174.
8. Conover MS, Mishra M & Deora R (2011) Extracellular DNA is essential for maintaining Bordetella biofilm integrity on abiotic surfaces and in the upper respiratory tract of mice. PLoS ONE 6: e16861.
9. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR & Lappin-Scott HM (1995) Microbial biofilms. Annu Rev Microbiol 49: 711-745.
10. Cuaron JA, Dulal S, Song Y, Singh AK, Montelongo CE, Yu W, Nagarajan V, Jayaswal RK, Wilkinson BJ & Gustafson JE (2012) Tea tree oil-induced transcriptional alterations in Staphylococcus aureus. Phytother Res doi: 10.1002/ptr.4738.
11. Donlan RM & Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193.
12. Fitzpatrick F, Humphreys H & O'Gara JP (2005) Evidence for icaADBC-independent biofilm development mechanism in methicillin-resistant Staphylococcus aureus clinical isolates. J Clin Microbiol 43: 1973-1976.
13. Foster TJ (2005) Immune evasion by staphylococci. Nat Rev Microbiol 3: 948-958.
14. Gilbert P & McBain AJ (2003) Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev 16: 189-208.
15. Gotz F (2002) Staphylococcus and biofilms. Mol Microbiol 43: 1367-1378.
16. Iwatsuki K, Yamasaki O, Morizane S & Oono T (2006) Staphylococcal cutaneous infections: invasion, evasion and aggression. J Dermatol Sci 42: 203-214.
17. Johnson M, Cockayne A & Morrissey JA (2008) Iron-regulated biofilm formation in Staphylococcus aureus Newman requires ica and the secreted protein Emp. Infect Immun 76: 1756-1765.
18. Kaatz GW, DeMarco CE & Seo SM (2006) MepR, a repressor of the Staphylococcus aureus MATE family multidrug efflux pump MepA, is a substrate-responsive regulatory protein. Antimicrob Agents Chemother 50: 1276-1281.
19. Kadouri D, Venzon NC & O'Toole GA (2007) Vulnerability of pathogenic biofilms to Micavibrio aeruginosavorus. Appl Environ Microbiol 73: 605-614.
20. Knobloch JK-M, Horstkotte MA, Rohde H, Kaulfers P-M & Mack D (2002) Alcoholic ingredients in skin disinfectants increase biofilm expression of Staphylococcus epidermidis. J Antimicrob Chemother 49: 683-687.
21. Kogan G, Sadovskaya I, Chaignon P, Chokr A & Jabbouri S (2006) Biofilms of clinical strains of Staphylococcus that do not contain polysaccharide intercellular adhesin. FEMS Microbiol Lett 255: 11-16.
22. Korem M, Gov Y, Shirron N, Shuster A & Rosenberg M (2007) Alcohol increases hemolysis by staphylococci. FEMS Microbiol Lett 269: 153-159.
23. Korem M, Gov Y & Rosenberg M (2010) Global gene expression in Staphylococcus aureus following exposure to alcohol. Microb Pathog 48: 74-84.
24. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532.
25. Mah TF & O'Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9: 34-39.
26. McDonnell G & Russell AD (1999) Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 12: 147-179.
27. Milisavljevic V, Tran LP, Batmalle C & Bootsma HJ (2008) Benzyl alcohol and ethanol can enhance the pathogenic potential of clinical Staphylococcus epidermidis strains. Am J Infect Control 36: 552-558.
28. O'Gara JP (2007) ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett 270: 179-188.
29. O'Toole GA & Kolter R (1998) Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 28: 449-461.
30. Peng HL, Novick RP, Kreiswirth B, Kornblum J & Schlievert P (1988) Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J Bacteriol 170: 4365-4372.
31. Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, Franks KS & Horton ML (2005) Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother 49: 2612-2617.
32. Resch A, Rosenstein R, Nerz C & Gotz F (2005) Differential gene expression profiling of Staphylococcus aureus cultivated under biofilm and planktonic conditions. Appl Environ Microbiol 71: 2663-2676.
33. Shanks RM, Donegan NP, Graber ML, Buckingham SE, Zegans ME, Cheung AL & O'Toole GA (2005) Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 73: 4596-4606.
34. Trotonda MP, Tamber S, Memmi G & Cheung AL (2008) MgrA represses biofilm formation in Staphylococcus aureus. Infect Immun 76: 5645-5654.
35. Walker TS, Tomlin KL, Worthen GS, Poch KR, Lieber JG, Saavedra MT, Fessler MB, Malcolm KC, Vasil ML & Nick JA (2005) Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immun 73: 3693-3701.